Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

M Hirsch, J O'donnell, A Olsson - International journal of cardiology, 2005 - Elsevier
BACKGROUND: Lowering low-density lipoprotein cholesterol (LDL-C) levels reduces the
risk of coronary heart disease. The introduction of a highly efficacious new statin …
被引用次数：28 相关文章

Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

M Hirsch, J O'Donnell, A Olsson - International …, 2005 - internationaljournalofcardiology.com
Background Lowering low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of
coronary heart disease. The introduction of a highly efficacious new statin, rosuvastatin, may …

Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals.

M Hirsch, J O'donnell, A Olsson - International Journal of Cardiology, 2005 - europepmc.org
Background Lowering low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of
coronary heart disease. The introduction of a highly efficacious new statin, rosuvastatin, may …

Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

M Hirsch, J O'donnell, A Olsson - International journal of …, 2005 - pubmed.ncbi.nlm.nih.gov
Background Lowering low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of
coronary heart disease. The introduction of a highly efficacious new statin, rosuvastatin, may …

[引用][C] Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

M HIRSCH, J O'DONNELL… - International journal of …, 2005 - pascal-francis.inist.fr
Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

M Hirsch, A Olsson - International Journal of Cardiology, 2005 - swepub.kb.se
Background: Lowering low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of
coronary heart disease. The introduction of a highly efficacious new statin, rosuvastatin, may …

Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

M Hirsch, J O'Donnell, A Olsson - International Journal of Cardiology, 2005 - infona.pl
Lowering low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of coronary
heart disease. The introduction of a highly efficacious new statin, rosuvastatin, may enable …

Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

M Hirsch, A Olsson - International Journal of Cardiology, 2005 - diva-portal.org
Background: Lowering low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of
coronary heart disease. The introduction of a highly efficacious new statin, rosuvastatin, may …

Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

M Hirsch, A Olsson - International Journal of Cardiology, 2005 - swepub.kb.se
Background: Lowering low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of
coronary heart disease. The introduction of a highly efficacious new statin, rosuvastatin, may …

[引用][C] Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

M HIRSCH, J O'DONNELL, A OLSSON - International journal of cardiology, 2005 - Elsevier